Source: European Medicines Agency (EU) Revision Year: 2022 Publisher: Tetris Pharma B.V, Bargelaan 200, Element Offices, 2333 CW Leiden, Netherlands
Ogluo 0.5 mg solution for injection in pre-filled pen.
Ogluo 1 mg solution for injection in pre-filled pen.
Ogluo 0.5 mg solution for injection in pre-filled syringe.
Ogluo 1 mg solution for injection in pre-filled syringe.
Pharmaceutical Form |
---|
Solution for injection (injection). A clear, colourless to pale yellow solution. |
Ogluo 0.5 mg solution for injection in pre-filled pen: Each pre-filled pen contains 0.5 mg glucagon in 0.1 mL.
Ogluo 1 mg solution for injection in pre-filled pen: Each pre-filled pen contains 1 mg glucagon in 0.2 mL.
Ogluo 0.5 mg solution for injection in pre-filled syringe: Each pre-filled syringe contains 0.5 mg glucagon in 0.1 mL.
Ogluo 1 mg solution for injection in pre-filled syringe: Each pre-filled syringe contains 1 mg glucagon in 0.2 mL.
For the full list of excipients, see section 6.1.
Active Ingredient | Description | |
---|---|---|
Glucagon |
Glucagon is a hyperglycaemic agent that mobilises hepatic glycogen, which is released into the blood as glucose. Glucagon inhibits the tone and motility of the smooth muscle in the gastrointestinal tract. |
List of Excipients |
---|
Trehalose dihydrate |
Ogluo 0.5 mg solution for injection in pre-filled pen:
A pre-filled, single-dose pen containing a 1 mL cyclic olefin polymer syringe with ETFE coated chlorobutyl rubber piston, 27-gauge staked stainless steel needle,bromo butyl rubber flexible needle shield, and a red cap.
Each pre-filled pen contain 0.1 mL of solution for injection and is individually packaged in a predominantly red-coloured foil pouch, in a red on white carton displaying a pre-filled pen image.
Pack sizes of one and two single-dose pre-filled pens.
Ogluo 1 mg solution for injection in pre-filled pen:
A pre-filled, single-dose pen containing a 1 mL cyclic olefin polymer syringe with ETFE coated chlorobutyl rubber piston, 27-gauge staked stainless steel needle,bromo butyl rubber flexible needle shield, and a red cap.
Each pre-filled pen contains 0.2 mL of solution for injection and is individually packaged in a predominantly blue-coloured foil pouch, in a blue on white carton displaying a pre-filled pen image.
Pack sizes of one and two single-dose pre-filled pens.
Ogluo 0.5 mg solution for injection in pre-filled syringe:
A pre-filled 1 mL cyclic olefin polymer syringe with ETFE coated chlorobutyl rubber piston, 27-gauge staked stainless steel needle, and bromo butyl rubber rigid needle shield. Each syringe contains 0.1 mL of solution for injection and is individually packaged in a predominantly red-coloured foil pouch, in a red on white carton displaying a pre-filled syringe image.
Pack sizes of one and two single-dose pre-filled syringes.
Ogluo 1 mg solution for injection in pre-filled syringe:
A pre-filled 1 mL cyclic olefin polymer syringe with ETFE coated chlorobutyl rubber piston, 27-gauge staked stainless steel needle, and bromo butyl rubber rigid needle shield. Each syringe contains 0.2 mL of solution for injection and is individually packaged in a predominantly blue-coloured foil pouch, in a blue on white carton displaying a pre-filled syringe image.
Pack sizes of one and two single-dose pre-filled syringes.
Not all pack sizes may be marketed.
Tetris Pharma B.V, Bargelaan 200, Element Offices, 2333 CW Leiden, Netherlands
EU/1/20/1523/001
EU/1/20/1523/002
EU/1/20/1523/003
EU/1/20/1523/004
EU/1/20/1523/005
EU/1/20/1523/006
EU/1/20/1523/007
EU/1/20/1523/008
Date of first authorisation: 11 February 2021
Drug | Countries | |
---|---|---|
OGLUO | Estonia, Croatia, Ireland, Lithuania, Poland |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.